GSE233679 nicotinamide 14 v 4 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE233679_nicotinamide_14_v_4_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE233679_nicotinamide_14_v_4_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE233679_nicotinamide_14_v_4_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE233679_nicotinamide_14_v_4_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

HLA complex P5

Gene

long intergenic non-protein coding RNA 1291

Gene

ALDH1A3 antisense RNA 1

Gene

BST2 interferon stimulated positive regulator

Gene

FOXF1 adjacent non-coding developmental regulatory RNA

Gene

LY6S antisense RNA 1

Gene

chromosome 10 putative open reading frame 55

Gene

uncharacterized LOC105375523

Gene

FOXF2 divergent transcript

Gene

H4 clustered histone 6


  • Gene

    long intergenic non-protein coding RNA 1291


  • Gene

    ALDH1A3 antisense RNA 1


  • Gene

    BST2 interferon stimulated positive regulator


  • Gene

    FOXF1 adjacent non-coding developmental regulatory RNA


  • Gene

    LY6S antisense RNA 1


  • Gene

    chromosome 10 putative open reading frame 55


  • Gene

    uncharacterized LOC105375523


  • Gene

    FOXF2 divergent transcript


  • Gene

    H4 clustered histone 6

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.